Stimson Susan P
Chief Strategy Officer at Intersect ENT, Inc.
- Sold, on record
- $915k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Jun 13, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Intersect ENT, Inc.Chief Strategy Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Intersect ENT, Inc.Plan not statedApr 10 2019
Sold 10,000 shares at $29.13 ($291k)
Stimson Susan P, Chief Strategy Officer
Sold 17.9% of holdings ($1.6M position)45,778 shares leftFirst sale on recordFiling
- 2 Form 4 sale Intersect ENT, Inc.Plan not statedApr 23 +13 days
Sold 2,663 shares at $30.00 ($80k)
Stimson Susan P, Chief Strategy Officer
Sold 5.8% of holdings ($1.4M position)43,115 shares leftFiling
- 3 Form 4 sale Intersect ENT, Inc.UnusualApr 29 +6 days
Sold 12,500 shares at $31.06 ($388k)
Stimson Susan P, Chief Strategy Officer
Sold 34.2% of holdings ($1.1M position)24,030 shares leftFiling
- 4 Form 4 sale Intersect ENT, Inc.Plan not statedMay 10 +11 days
Sold 5,350 shares at $27.38 ($146k)
Stimson Susan P, Chief Strategy Officer
Sold 12.9% of holdings ($1.1M position)35,982 shares left0.5x usual sizeFiling
- 5 Form 4 sale Intersect ENT, Inc.Plan not statedJun 13 +34 days
Sold 350 shares at $25.00 ($9k)
Stimson Susan P, Chief Strategy Officer
Sold 1% of holdings ($908k position)35,982 shares left0x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2019 | Intersect ENT, Inc. | Chief Strategy Officer | Form 4 sale | 350 | $9k | 1.0% | Plan not stated | SEC |
| May 10, 2019 | Intersect ENT, Inc. | Chief Strategy Officer | Form 4 sale | 5,350 | $146k | 12.9% | Plan not stated | SEC |
| Apr 29, 2019 | Intersect ENT, Inc. | Chief Strategy Officer | Form 4 sale | 12,500 | $388k | 34.2% | Unusual | SEC |
| Apr 23, 2019 | Intersect ENT, Inc. | Chief Strategy Officer | Form 4 sale | 2,663 | $80k | 5.8% | Plan not stated | SEC |
| Apr 10, 2019 | Intersect ENT, Inc. | Chief Strategy Officer | Form 4 sale | 10,000 | $291k | 17.9% | Plan not stated | SEC |